Fit the patient morphology with the appropriated probe
The mobile non-invasive solution for liver disease management, ideal for multi-site configuration
Powered by LSM by VCTE™ and CAP™* for liver fibrosis and liver steatosis assessment.
FibroScan® Mini+ 430 is designed for multi-center sharing and remote liver patient management.
LSM by VCTE™ is unique, patented and validated for liver fibrosis assessment. It is the standard for non-invasive evaluation of liver stiffness with 2,750 international peer-reviewed publications.1
CAP™ is unique patented and validated for liver steatosis assessment2,3 with 605 international peer-reviewed publications.
*CAP™ is available as an option.
Assessment of liver stiffness and fat by non-invasive method is a huge step forward towards better management of NAFLD. It has hugely impacted the way clinicians stratify the patients, chose therapy and monitor response!
Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459). These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.
References are available in our bibliography.